Related Experiment Video
Updated: Feb 18, 2026

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
Published on: May 24, 2024
The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5
1Institute of Infection and Immunity, School of Medicine, Cardiff University, Henry Wellcome Building, Heath Park, Cardiff, CF14 4XN, UK. richard.alexander.harrison@outlook.com.
Insights
The alternative pathway of complement activation primarily amplifies C3 and C5, not just C3. This surface-dependent loop targets surfaces for elimination, crucial for understanding diseases and therapies.
Area of Science:
- Immunology
- Complement System Biology
Background:
- The alternative pathway of complement activation is traditionally viewed as a distinct route for C3 activation.
- Existing literature provides comprehensive reviews on the discovery and evolution of this pathway.
Purpose of the Study:
- To contextualize current concepts of the alternative pathway.
- To challenge the prevailing textbook view of the alternative pathway's primary role.
- To propose the system's main function as a surface-dependent amplification loop for C3 and C5 activation.
Main Methods:
- Literature review and conceptual analysis.
- Re-evaluation of the established role of complement components.
- Development of an argument for a revised understanding of the alternative pathway's function.
Main Results:
- The alternative pathway's primary role is redefined as a surface-dependent amplification loop for C3 and C5 activation.
- Surface deposition of C3b initiates a targeted elimination process.
- A sophisticated amplification loop regulates the targeting and elimination of surfaces.
Conclusions:
- The alternative pathway functions as a critical amplification loop for complement activation, targeting surfaces for elimination.
- Understanding this amplification loop is essential for developing therapies for diseases linked to complement dysregulation.
- Therapeutic strategies must address the complexities and challenges of modulating this amplification loop.
Abstract:
This review is not intended to cover in detail all aspects of the discovery and evolution of our understanding of the "alternative pathway" of complement activation, there are many excellent reviews that do this (see Fearon (CRC Crit Rev Immunol 1:1-32, 1979), Pangburn and Müller-Eberhard (Springer Semin Immunopathol 7:163-192, 1984)), but instead to give sufficient background for current concepts to be put in context. The prevailing textbook view, of components having a primary role as an alternative "pathway" for C3 activation, is challenged, with an argument developed for the primary role of the system being that of providing a surface-dependent amplification loop for both C3 and C5 activation. Whatever the mechanism by which the initial C3b molecule is generated, deposition onto a surface has the potential to target that surface for elimination. Elimination or escape from initial targeting is determined by a sophisticated and highly regulated amplification loop for C3 activation. This viewpoint of the system is then briefly developed to provide a context for therapeutic treatment of disease caused, at least in part, by dysregulated amplification of C3 activation, and to highlight some of the challenges that such therapies will face and need to address.
Related Concept Videos
Complement System
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
IP3/DAG Signaling Pathway
Antigen Processing Pathways
MHC Class I: Presenting Endogenous...
Amplifying Signals via Enzymatic Cascade
Intracellular Signaling Cascades

